On the other hand, a selective MC3R agonist did not show protective effects in models of middle cerebral artery occlusion [43] or global cerebral ischemia [17], which supports MC4R as the main mediator of NDP-α-MSH protective effects in the brain. The gene discussed is STAMBP; the disease is medical procedure.